Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4217239
Max Phase: Preclinical
Molecular Formula: C41H42ClF4N7O8S
Molecular Weight: 904.34
Molecule Type: Small molecule
Associated Items:
ID: ALA4217239
Max Phase: Preclinical
Molecular Formula: C41H42ClF4N7O8S
Molecular Weight: 904.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CC(=O)N(C[C@@H](NC(=O)Nc2nc(Cl)c(Cc3ccccc3)n(CC(=O)Nc3cc(F)ccc3C(=O)NS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2=O)C(C)(C)C)C(=O)C1
Standard InChI: InChI=1S/C41H42ClF4N7O8S/c1-39(2,3)30(21-53-32(55)19-40(4,5)20-33(53)56)48-38(59)50-35-37(58)52(29(34(42)49-35)17-23-9-7-6-8-10-23)22-31(54)47-28-18-25(43)13-16-27(28)36(57)51-62(60,61)26-14-11-24(12-15-26)41(44,45)46/h6-16,18,30H,17,19-22H2,1-5H3,(H,47,54)(H,51,57)(H2,48,49,50,59)/t30-/m1/s1
Standard InChI Key: RPZUMNMATJQMKI-SSEXGKCCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 904.34 | Molecular Weight (Monoisotopic): 903.2440 | AlogP: 6.11 | #Rotatable Bonds: 12 |
Polar Surface Area: 205.74 | Molecular Species: ACID | HBA: 10 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.24 | CX Basic pKa: | CX LogP: 6.20 | CX LogD: 5.26 |
Aromatic Rings: 4 | Heavy Atoms: 62 | QED Weighted: 0.10 | Np Likeness Score: -1.24 |
1. Belfrage AK, Abdurakhmanov E, Åkerblom E, Brandt P, Alogheli H, Neyts J, Danielson UH, Sandström A.. (2018) Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold., 148 [PMID:29477077] [10.1016/j.ejmech.2018.02.032] |
Source(1):